Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis

米力农 多巴酚丁胺 医学 变向性 心源性休克 心脏病学 重症监护室 内科学 麻醉 血流动力学 心肌梗塞
作者
Rebecca Mathew,Sarah Visintini,F. Daniel Ramirez,Pietro DiSanto,Trevor Simard,Marino Labinaz,Benjamin Hibbert
出处
期刊:Clinical and Investigative Medicine 卷期号:42 (2): E26-32 被引量:23
标识
DOI:10.25011/cim.v42i2.32813
摘要

Patients in cardiac intensive care units (ICU) are admitted with increasingly higher disease acuity and a larger burden of non-cardiac critical illness. Accordingly, positive inotropes are being used with increased frequency and little comparative data to support drug selection. We compared the effectiveness and safety of dobutamine and milrinone in low cardiac output states (LCOS) and/or cardiogenic shock (CS).We performed a systematic review comparing dobutamine to milrinone on all-cause mortality, length of stay in the ICU (LOS-ICU), length of stay in hospital (LOS-H) and significant arrhythmias in hospitalized patients with LCOS and/or CS.We identified 11 studies that meet eligibility requirements and which were published between 2001 and 2016 and included 23,056 patients. Only one randomized clinical trial was identified, with the remaining studies comprising observational cohort studies. The primary outcome, all-cause mortality, trended towards a benefit with milrinone but did not meet pre-specified significance (OR 1.13, 95% CI 1.00-1.29, p=0.06). While LOS-ICU (mean difference -0.72, 95% CI -1.10- -0.34, p=0.0002) was shorter with dobutamine, there was no difference in LOS-H (mean difference -1.22, 95% CI -4.68 - 2.24, p=0.49). Significant arrhythmias, specifically symptomatic and/or requiring antiarrhythmic therapy, were no different between the groups (OR 1.78, 95% CI 0.85-3.76, p=0.13).Currently available data comparing milrinone to dobutamine in patients requiring inotropic support is limited. Dobutamine may be associated with a shorter LOS in the ICU, with a worrisome signal of increased risk of allcause mortality. Randomized data are needed to guide inotrope selection in patients with LCOS and/or CS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
风轩轩发布了新的文献求助30
刚刚
花园荆棘完成签到,获得积分10
刚刚
干净惜蕊完成签到,获得积分10
2秒前
研友_LaV1xn发布了新的文献求助10
3秒前
月蚀六花完成签到,获得积分10
4秒前
TAKERA发布了新的文献求助10
4秒前
momo完成签到,获得积分10
4秒前
CodeCraft应助Jim luo采纳,获得10
5秒前
姜姜姜完成签到 ,获得积分10
6秒前
9秒前
研友_LaV1xn完成签到,获得积分10
10秒前
11秒前
14秒前
zyx174733完成签到,获得积分10
14秒前
Jim luo发布了新的文献求助10
15秒前
15秒前
16秒前
自然寻菱发布了新的文献求助10
17秒前
mtfx发布了新的文献求助10
19秒前
舒心的幻天完成签到,获得积分10
19秒前
徐芳菲发布了新的文献求助10
21秒前
成长中完成签到 ,获得积分10
21秒前
21秒前
丰富幻悲完成签到 ,获得积分10
22秒前
lyh完成签到,获得积分10
24秒前
24秒前
英姑应助缥缈南风采纳,获得10
24秒前
merryorange发布了新的文献求助20
28秒前
TAKERA完成签到 ,获得积分10
29秒前
xiaoyun2852应助xingyi采纳,获得80
32秒前
SUSTZJB完成签到 ,获得积分10
34秒前
ananan关注了科研通微信公众号
35秒前
聪明的青雪完成签到,获得积分10
35秒前
凤凰之玉发布了新的文献求助10
36秒前
SUSTZJB关注了科研通微信公众号
39秒前
john发布了新的文献求助10
40秒前
zxxydnksnn完成签到 ,获得积分10
41秒前
Lvy完成签到,获得积分10
41秒前
wanci应助巫雍采纳,获得10
42秒前
冷漠的冰激凌完成签到,获得积分10
42秒前
高分求助中
中国国际图书贸易总公司40周年纪念文集 大事记1949-1987 2000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
草地生态学 880
Threaded Harmony: A Sustainable Approach to Fashion 799
Basic Modern Theory of Linear Complex Analytic 𝑞-Difference Equations 510
Queer Politics in Times of New Authoritarianisms: Popular Culture in South Asia 500
Livre et militantisme : La Cité éditeur 1958-1967 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3058597
求助须知:如何正确求助?哪些是违规求助? 2714676
关于积分的说明 7441656
捐赠科研通 2360028
什么是DOI,文献DOI怎么找? 1250485
科研通“疑难数据库(出版商)”最低求助积分说明 607447
版权声明 596421